Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Ranging Study of IV Oxytocin for Analgesia
NCT05179421Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2022
- Primary completion
- Feb 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in pain (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Dose Response of Intravenous Oxytocin on Sustained Heat Pain. Started May 2022; status: completed.
02
Drugs
oxytocin
03
Conditions
pain
Beyond the preview
Go deeper on NCT05179421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05179421.